Licensed human natural killer cells aid dendritic cell maturation via TNFSF14/LIGHT

Proceedings of the National Academy of Sciences of the United States of America

Volumn 111, Issue 52, 2014, Pages E5688-E5696

  Holmes, Tim D ^a,d   Wilson, Erica B ^a   Black, Emma V I ^a   Benest, Andrew V ^a,e   Vaz, Candida ^b   Tan, Betty ^b   Tanavde, Vivek M ^b,c   Cook, Graham P ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b BIOINFORMATICS INSTITUTE   (Singapore)

^c INSTITUTE OF MEDICAL BIOLOGY   (Singapore)

^d KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^e UNIVERSITY OF NOTTINGHAM   (United Kingdom)

Author keywords

Natural killer cells; NK cell licensing; NK DC interactions; TNFSF14; Tumor immunity

Indexed keywords

CD69 ANTIGEN; CD86 ANTIGEN; FAS LIGAND; GAMMA INTERFERON; GRANULOCYTE MACROPHAGE COLONY STIMULATING FACTOR; HERPESVIRUS ENTRY MEDIATOR LIGAND; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERCELLULAR ADHESION MOLECULE 1; INTERLEUKIN 12; INTERLEUKIN 15; INTERLEUKIN 18; INTERLEUKIN 2; IONOMYCIN; KILLER CELL IMMUNOGLOBULIN LIKE RECEPTOR; NATURAL KILLER CELL RECEPTOR NKG2A; PHORBOL 13 ACETATE 12 MYRISTATE; PROTEIN; TNFSF2 PROTEIN; TUMOR NECROSIS FACTOR RECEPTOR ASSOCIATED FACTOR; UNCLASSIFIED DRUG; VASCULAR ENDOTHELIAL GROWTH INHIBITOR; FC RECEPTOR; FCGR3B PROTEIN, HUMAN; GLYCOSYLPHOSPHATIDYLINOSITOL ANCHORED PROTEIN; IL15 PROTEIN, HUMAN; IL2 PROTEIN, HUMAN; TNFSF14 PROTEIN, HUMAN;

ANIMAL CELL; ARTICLE; CELL ACTIVATION; CELL MATURATION; CELL SURFACE; COCULTURE; CROSS LINKING; CYTOKINE PRODUCTION; CYTOTOXICITY; DEGRANULATION; DENDRITIC CELL; EXOCYTOSIS; FLUORESCENCE ACTIVATED CELL SORTING; GENE EXPRESSION; GENE EXPRESSION PROFILING; HUMAN; HUMAN CELL; IMMUNOSURVEILLANCE; NATURAL KILLER CELL; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; QUANTITATIVE ANALYSIS; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T LYMPHOCYTE; TARGET CELL; TUMOR CELL; UPREGULATION; CELL COMMUNICATION; CYTOLOGY; FEMALE; IMMUNOLOGY; K562 CELL LINE; LYMPHOCYTE ACTIVATION; MALE; NEOPLASM;

SIMPLEXVIRUS;

CELL COMMUNICATION; COCULTURE TECHNIQUES; DENDRITIC CELLS; FEMALE; GPI-LINKED PROTEINS; HUMANS; IMMUNOLOGIC SURVEILLANCE; INTERLEUKIN-15; INTERLEUKIN-2; K562 CELLS; KILLER CELLS, NATURAL; LYMPHOCYTE ACTIVATION; MALE; NEOPLASMS; RECEPTORS, IGG; TUMOR NECROSIS FACTOR LIGAND SUPERFAMILY MEMBER 14;

EID: 84924352771     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.1411072112     Document Type: Article

References (67)

1. Vivier E, et al. (2011) Innate or adaptive immunity? The example of natural killer cells. Science 331(6013):44-49.
2. Vivier E, Tomasello E, Baratin M, Walzer T, Ugolini S (2008) Functions of natural killer cells. Nat Immunol 9(5):503-510.
3. Piccioli D, Sbrana S, Melandri E, Valiante NM (2002) Contact-dependent stimulation and inhibition of dendritic cells by natural killer cells. J Exp Med 195(3):335-341.
4. Gerosa F, et al. (2002) Reciprocal activating interaction between natural killer cells and dendritic cells. J Exp Med 195(3):327-333.
5. Vitale M, et al. (2005) NK-dependent DC maturation is mediated by TNFalpha and IFNgamma released upon engagement of the NKp30 triggering receptor. Blood 106(2):566-571.
6. Martín-Fontecha A, et al. (2004) Induced recruitment of NK cells to lymph nodes provides IFN-gamma for T(H)1 priming. Nat Immunol 5(12):1260-1265.
7. Morandi B, Bougras G, Muller WA, Ferlazzo G, Münz C (2006) NK cells of human secondary lymphoid tissues enhance T cell polarization via IFN-gamma secretion. Eur J Immunol 36(9):2394-2400.
8. Caligiuri MA (2008) Human natural killer cells. Blood 112(3):461-469.
9. Lanier LL (2008) Up on the tightrope: Natural killer cell activation and inhibition. Nat Immunol 9(5):495-502.
10. Long EO, Kim HS, Liu D, Peterson ME, Rajagopalan S (2013) Controlling natural killer cell responses: Integration of signals for activation and inhibition. Annu Rev Immunol 31:227-258.
11. Kim S, et al. (2005) Licensing of natural killer cells by host major histocompatibility complex class I molecules. Nature 436(7051):709-713.
12. Anfossi N, et al. (2006) Human NK cell education by inhibitory receptors for MHC class I. Immunity 25(2):331-342.
13. Kim S, et al. (2008) HLA alleles determine differences in human natural killer cell responsiveness and potency. Proc Natl Acad Sci USA 105(8):3053-3058.
14. Elliott JM, Yokoyama WM (2011) Unifying concepts of MHC-dependent natural killer cell education. Trends Immunol 32(8):364-372.
15. Mauri DN, et al. (1998) LIGHT, a new member of the TNF superfamily, and lymphotoxin alpha are ligands for herpesvirus entry mediator. Immunity 8(1):21-30.
16. Hanna J, et al. (2004) Novel insights on human NK cells' immunological modalities revealed by gene expression profiling. J Immunol 173(11):6547-6563.
17. Bezman NA, et al.; Immunological Genome Project Consortium (2012) Molecular definition of the identity and activation of natural killer cells. Nat Immunol 13(10):1000-1009.
18. Walzer T, Jaeger S, Chaix J, Vivier E (2007) Natural killer cells: From CD3(-)NKp46(+) to post-genomics meta-analyses. Curr Opin Immunol 19(3):365-372.
19. Yu J, et al. (2007) Hierarchy of the human natural killer cell response is determined by class and quantity of inhibitory receptors for self-HLA-B and HLA-C ligands. J Immunol 179(9):5977-5989.
20. Steinberg MW, Cheung TC, Ware CF (2011) The signaling networks of the herpesvirus entry mediator (TNFRSF14) in immune regulation. Immunol Rev 244(1):169-187.
21. Murphy TL, Murphy KM (2010) Slow down and survive: Enigmatic immunoregulation by BTLA and HVEM. Annu Rev Immunol 28:389-411.
22. Cai G, et al. (2008) CD160 inhibits activation of human CD4+ T cells through interaction with herpesvirus entry mediator. Nat Immunol 9(2):176-185.
23. Marsters SA, et al. (1997) Herpesvirus entry mediator, a member of the tumor necrosis factor receptor (TNFR) family, interacts with members of the TNFR-associated factor family and activates the transcription factors NF-kappaB and AP-1. J Biol Chem 272(22):14029-14032.
24. Hsu H, et al. (1997) ATAR, a novel tumor necrosis factor receptor family member, signals through TRAF2 and TRAF5. J Biol Chem 272(21):13471-13474.
25. Ware CF, Sedý JR (2011) TNF Superfamily Networks: Bidirectional and interference pathways of the herpesvirus entry mediator (TNFSF14). Curr Opin Immunol 23(5): 627-631.
26. Frey M, et al. (1998) Differential expression and function of L-selectin on CD56bright and CD56dim natural killer cell subsets. J Immunol 161(1):400-408.
27. Welsh RM, Waggoner SN (2013) NK cells controlling virus-specific T cells: Rheostats for acute vs. persistent infections. Virology 435(1):37-45.
28. Vidal SM, Khakoo SI, Biron CA (2011) Natural killer cell responses during viral infections: Flexibility and conditioning of innate immunity by experience. Curr Opin Virol 1(6):497-512.
29. Lucas M, Schachterle W, Oberle K, Aichele P, Diefenbach A (2007) Dendritic cells prime natural killer cells by trans-presenting interleukin 15. Immunity 26(4):503-517.
30. Scheller J, Chalaris A, Garbers C, Rose-John S (2011) ADAM17: A molecular switch to control inflammation and tissue regeneration. Trends Immunol 32(8):380-387.
31. Morel Y, et al. (2000) Reciprocal expression of the TNF family receptor herpes virus entry mediator and its ligand LIGHT on activated T cells: LIGHT down-regulates its own receptor. J Immunol 165(8):4397-4404.
32. Morel Y, Truneh A, Sweet RW, Olive D, Costello RT (2001) The TNF superfamily members LIGHT and CD154 (CD40 ligand) costimulate induction of dendritic cell maturation and elicit specific CTL activity. J Immunol 167(5):2479-2486.
33. Cooper MA, Fehniger TA, Fuchs A, Colonna M, Caligiuri MA (2004) NK cell and DC interactions. Trends Immunol 25(1):47-52.
34. Zou GM, Hu WY (2005) LIGHT regulates CD86 expression on dendritic cells through NF-kappaB, but not JNK/AP-1 signal transduction pathway. J Cell Physiol 205(3):437-443.
35. Madge LA, Kluger MS, Orange JS, May MJ (2008) Lymphotoxin-alpha 1 beta 2 and LIGHT induce classical and noncanonical NF-kappa B-dependent proinflammatory gene expression in vascular endothelial cells. J Immunol 180(5):3467-3477.
36. Tamada K, et al. (2000) Modulation of T-cell-mediated immunity in tumor and graft-versus-host disease models through the LIGHT co-stimulatory pathway. Nat Med 6(3):283-289.
37. Yu P, et al. (2004) Priming of naive T cells inside tumors leads to eradication of established tumors. Nat Immunol 5(2):141-149.
38. Cohavy O, Zhou J, Ware CF, Targan SR (2005) LIGHT is constitutively expressed on T and NK cells in the human gut and can be induced by CD2-mediated signaling. J Immunol 174(2):646-653.
39. Zhu M, Yang Y, Wang Y, Wang Z, Fu YX (2011) LIGHT regulates inflamed draining lymph node hypertrophy. J Immunol 186(12):7156-7163.
40. Tamada K, et al. (2000) LIGHT, a TNF-like molecule, costimulates T cell proliferation and is required for dendritic cell-mediated allogeneic T cell response. J Immunol 164(8):4105-4110.
41. Cheung TC, et al. (2009) T cell intrinsic heterodimeric complexes between HVEM and BTLA determine receptivity to the surrounding microenvironment. J Immunol 183(11):7286-7296.
42. Fernandez NC, et al. (1999) Dendritic cells directly trigger NK cell functions: Cross-talk relevant in innate anti-tumor immune responses in vivo. Nat Med 5(4):405-411.
43. Ferlazzo G, et al. (2002) Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells. J Exp Med 195(3):343-351.
44. Šedý JR, et al. (2013) CD160 activation by herpesvirus entry mediator augments inflammatory cytokine production and cytolytic function by NK cells. J Immunol 191(2):828-836.
45. Koka R, et al. (2004) Cutting edge: Murine dendritic cells require IL-15R alpha to prime NK cells. J Immunol 173(6):3594-3598.
46. Boyman O, Sprent J (2012) The role of interleukin-2 during homeostasis and activation of the immune system. Nat Rev Immunol 12(3):180-190.
47. Björkström NK, et al. (2011) Rapid expansion and long-term persistence of elevated NK cell numbers in humans infected with hantavirus. J Exp Med 208(1):13-21.
48. Sun JC, Beilke JN, Lanier LL (2009) Adaptive immune features of natural killer cells. Nature 457(7229):557-561.
49. +NKG2Chi natural killer cell subset during acute human cytomegalovirus infection. Proc Natl Acad Sci USA 108(36):14725-14732.
50. Lang PA, et al. (2012) Natural killer cell activation enhances immune pathology and promotes chronic infection by limiting CD8+ T-cell immunity. Proc Natl Acad Sci USA 109(4):1210-1215.
51. Waggoner SN, Cornberg M, Selin LK, Welsh RM (2012) Natural killer cells act as rheostats modulating antiviral T cells. Nature 481(7381):394-398.
52. Shaw G, Kamen R (1986) A conserved AU sequence from the 3′ untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46(5):659-667.
53. Stumpo DJ, Lai WS, Blackshear PJ (2010) Inflammation: Cytokines and RNA-based regulation. Wiley Interdiscip Rev RNA 1(1):60-80.
54. Castellano R, et al. (2002) Mechanisms regulating expression of the tumor necrosis factor-related light gene. Role of calcium-signaling pathway in the transcriptional control. J Biol Chem 277(45):42841-42851.
55. Bryceson YT, March ME, Ljunggren HG, Long EO (2006) Synergy among receptors on resting NK cells for the activation of natural cytotoxicity and cytokine secretion. Blood 107(1):159-166.
56. Fauriat C, Long EO, Ljunggren HG, Bryceson YT (2010) Regulation of human NK-cell cytokine and chemokine production by target cell recognition. Blood 115(11):2167-2176.
57. Doherty TA, et al. (2011) The tumor necrosis factor family member LIGHT is a target for asthmatic airway remodeling. Nat Med 17(5):596-603.
58. Ware CF (2009) Targeting the LIGHT-HVEM pathway. Adv Exp Med Biol 647:146-155.
59. Orr MT, Murphy WJ, Lanier LL (2010) 'Unlicensed' natural killer cells dominate the response to cytomegalovirus infection. Nat Immunol 11(4):321-327.
60. Betts MR, et al. (2003) Sensitive and viable identification of antigen-specific CD8+ T cells by a flow cytometric assay for degranulation. J Immunol Methods 281(1-2):65-78.
61. Meade JL, et al. (2009) Proteolytic activation of the cytotoxic phenotype during human NK cell development. J Immunol 183(2):803-813.
62. Holmes TD, et al. (2011) A human NK cell activation/inhibition threshold allows small changes in the target cell surface phenotype to dramatically alter susceptibility to NK cells. J Immunol 186(3):1538-1545.
63. Wilson EB, et al. (2011) Human tumour immune evasion via TGF-β blocks NK cell activation but not survival allowing therapeutic restoration of anti-tumour activity. PLoS ONE 6(9):e22842.
64. Walzer T, Dalod M, Robbins SH, Zitvogel L, Vivier E (2005) Natural-killer cells and dendritic cells: "L'union fait la force". Blood 106(7):2252-2258.
65. Santis AG, López-Cabrera M, Sánchez-Madrid F, Proudfoot N (1995) Expression of the early lymphocyte activation antigen CD69, a C-type lectin, is regulated by mRNA degradation associated with AU-rich sequence motifs. Eur J Immunol 25(8):2142-2146.
66. Mou Z, et al. (2012) HuR posttranscriptionally regulates early growth response-1 (Egr-1) expression at the early stage of T cell activation. FEBS Lett 586(24):4319-4325.
67. Drury GL, Di Marco S, Dormoy-Raclet V, Desbarats J, Gallouzi IE (2010) FasL expression in activated T lymphocytes involves HuR-mediated stabilization. J Biol Chem 285(41):31130-31138.